Portolan Capital Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Portolan Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $2.75 Million - $5.71 Million	-381,919 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.66 - $14.66 $459,153 - $1.01 Million	-68,942 Reduced 15.29%	381,919 $4.14 Million
Q3 2020 Nov 16, 2020	SELL	$8.69 - $14.47 $415,425 - $691,738	-47,805 Reduced 9.59%	450,861 $3.99 Million
Q2 2020 Aug 14, 2020	SELL	$5.21 - $11.03 $72,439 - $153,361	-13,904 Reduced 2.71%	498,666 $5.32 Million
Q1 2020 May 14, 2020	BUY	$4.46 - $9.2 $828,324 - $1.71 Million	185,723 Added 56.82%	512,570 $3.04 Million
Q4 2019 Feb 14, 2020	BUY	$4.52 - $10.1 $1.48 Million - $3.3 Million	326,847 New	326,847 $2.26 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Portolan Capital Management, LLC with notifications on news.